These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1685599)

  • 21. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion.
    Carson RE; Breier A; de Bartolomeis A; Saunders RC; Su TP; Schmall B; Der MG; Pickar D; Eckelman WC
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):437-47. PubMed ID: 9143226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.
    Perlmutter JS; Stambuk MK; Markham J; Black KJ; McGee-Minnich L; Jankovic J; Moerlein SM
    J Neurosci; 1997 Jan; 17(2):843-50. PubMed ID: 8987805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
    Logan J; Wolf AP; Shiue CY; Fowler JS
    J Neurochem; 1987 Jan; 48(1):73-83. PubMed ID: 2432176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
    Jovkar S; Wienhard K; Pawlik G; Coenen HH
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):720-6. PubMed ID: 2384543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.
    Mintun MA; Raichle ME; Kilbourn MR; Wooten GF; Welch MJ
    Ann Neurol; 1984 Mar; 15(3):217-27. PubMed ID: 6609679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 76Br-beta-CBT, a PET tracer for investigating dopamine neuronal uptake.
    Maziere B; Loc'h C; Müller L; Halldin C
    Nucl Med Biol; 1995 Nov; 22(8):993-7. PubMed ID: 8998477
    [No Abstract]   [Full Text] [Related]  

  • 29. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects.
    Logan J; Fowler JS; Volkow ND; Wolf AP; Dewey SL; Schlyer DJ; MacGregor RR; Hitzemann R; Bendriem B; Gatley SJ
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):740-7. PubMed ID: 2384545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of neocortical serotonin-2 receptor binding potential by single-dose fluorine-18-setoperone kinetic PET data analysis.
    Petit-Taboué MC; Landeau B; Osmont A; Tillet I; Barré L; Baron JC
    J Nucl Med; 1996 Jan; 37(1):95-104. PubMed ID: 8544011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
    Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
    Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands.
    Wong DF; Gjedde A; Wagner HN
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):137-46. PubMed ID: 2937794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.
    Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
    Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
    Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of high specific activity (-) and (+)-6-[18F]fluoronorepinephrine and 6-[18F]fluorodopamine in baboons: heart uptake, metabolism and the effect of desipramine.
    Ding YS; Fowler JS; Dewey SL; Logan J; Schlyer DJ; Gatley SJ; Volkow ND; King PT; Wolf AP
    J Nucl Med; 1993 Apr; 34(4):619-29. PubMed ID: 8455079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vivo evaluation of [18F]-N-(p-nitrobenzyl)spiperone ([18F]PNBS) in rats.
    Mach RH; Nowak PA; Moroney DA; Morton TE; Jackson JR; Ehrenkaufer RL
    Nucl Med Biol; 1993 Apr; 20(3):269-78. PubMed ID: 8485486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution volume ratios without blood sampling from graphical analysis of PET data.
    Logan J; Fowler JS; Volkow ND; Wang GJ; Ding YS; Alexoff DL
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):834-40. PubMed ID: 8784228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches.
    Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M
    J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.